Jennifer L Malin
Affiliation: Amgen Inc
- Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient surveyJennifer L Malin
Division of General Internal Medicine Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
Support Care Cancer 14:837-48. 2006..The keystone to this effort is the baseline patient survey administered approximately 4 months after diagnosis...
- Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?Jennifer L Malin
RAND Corporation, Santa Monica, CA, USA
J Clin Oncol 24:626-34. 2006....
- Symptoms after breast cancer treatment: are they influenced by patient characteristics?Jean Yoon
School of Public Health, Health Services, University of California at Los Angeles, Box 951772, Los Angeles, CA 90095 1722, USA
Breast Cancer Res Treat 108:153-65. 2008..This study examines the burden of symptoms by treatment type and patient characteristics in a population-based sample of newly diagnosed breast cancer patients...
- Symptom management after breast cancer treatment: is it influenced by patient characteristics?Jean Yoon
School of Public Health, Health Services Department, University of California at Los Angeles, Los Angeles, CA 90095 1772, USA
Breast Cancer Res Treat 108:69-77. 2008..We studied the extent to which symptoms for women with incident breast cancer are addressed by their physicians and how symptom management varies with patient characteristics...
- Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen useKatherine L Kahn
RAND, Santa Monica, California 90407 2138, USA
Med Care 45:431-9. 2007..Among breast cancer patients, tamoxifen use is associated with reduced risk of disease relapse and death, but it is often difficult for women to sustain therapy during the 5 years required to obtain maximum benefit...
- Quality of care for breast cancer for uninsured women in california under the breast and cervical cancer prevention treatment actJennifer L Malin
David Geffen School of Medicineat University of California, Los Angeles, CA, USA
J Clin Oncol 28:3479-84. 2010..The objective of this study was to evaluate the quality of care provided to uninsured women with breast cancer who received treatment through the Breast and Cervical Cancer Prevention Treatment Program (BCCTP)...
- The structural landscape of the health care system for breast cancer care: results from the Los Angeles Women's Health StudyDiana M Tisnado
Division of General Internal Medicine and Health Services Research, School of Medicine, University of California, Los Angeles, California 90095 1736, USA
Breast J 15:17-25. 2009..Data from this study represent important building blocks for further analyses to determine the impact of structural characteristics on the quality of care that breast cancer patient's experience...
- Facility characteristics and quality of lung cancer care in an integrated health care systemJoan J Ryoo
Veterans Administration Greater Los Angeles Healthcare System, West Los Angeles Los Angeles, California Jonsson Comprehensive Cancer Center, University of California, Los Angeles Los Angeles, California Department of Radiation Oncology, Kaiser Permanente Los Angeles Medical Center Los Angeles, California WellPoint, Inc, Indianapolis, Indiana Office of Informatics and Analytics, Veterans Health Administration Washington, District of Columbia Ordin Associates Silver Spring, Maryland Department of Medicine, Division of Hematology Oncology, University of California, San Francisco San Francisco, California Veterans Administration Palo Alto Healthcare System Palo Alto, California Division of General Medical Disciplines, Stanford School of Medicine Palo Alto, California Department of Biostatistics, University of California, Los Angeles Los Angeles, California and Department of Research and Evaluation, Kaiser Permanente Southern California Pasadena, California
J Thorac Oncol 9:447-55. 2014..In a national, integrated health care system, we sought to identify facility-level attributes associated with better quality of lung cancer care...
- Developing a reliable, valid, and feasible plan for quality-of-care measurement for cancer: how should we measure?Katherine L Kahn
RAND, Santa Monica, California 90406, USA
Med Care 40:III73-85. 2002..This effort will require a systematic evaluation of the measurement of quality of care as it applies to cancer and other critical conditions...
- Financial incentives for quality in breast cancer careDiana M Tisnado
Department of Medicine, University of California, Los Angeles, 911 Broxton Plz, Los Angeles, CA 90095 1736, USA
Am J Manag Care 14:457-66. 2008....
- Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort studyS Yousuf Zafar
Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
BMC Cancer 11:354. 2011..We describe early dissemination patterns for first-line bevacizumab given for metastatic colorectal cancer treatment...
- Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communicationYihang Liu
Department of Family Medicine, David Geffen School of Medicine, University of California, 10880 Wilshire Blvd, Los Angeles, CA 90024 7087, USA
Breast Cancer Res Treat 137:829-36. 2013..Interventions on patient-provider communication may provide opportunities to improve patient outcomes in this vulnerable population...
- Validity of cancer registry data for measuring the quality of breast cancer careJennifer L Malin
Divisions of General Internal Medicine Health Services Research, and Hematology Oncology, Department of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles 90095 1736, USA
J Natl Cancer Inst 94:835-44. 2002..The validity of cancer registry data for quality of cancer care has not been well studied. We investigated the validity of such information in the California Cancer Registry...
- Improving colorectal cancer screening rates in a managed care health plan: recruitment of provider organizations for a randomized effectiveness trialPatricia A Ganz
Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, School of Medicine, University of California, Los Angeles, California 90095 6900, USA
Cancer Epidemiol Biomarkers Prev 12:824-9. 2003..Successful implementation of programs that are feasible and take advantage of existing quality improvement mechanisms within the PO has potential to improve CRC screening rates and can have a major public health impact...
- Patient preference and contraindications in measuring quality of care: what do administrative data miss?Joan J Ryoo
Administration Greater Los Angeles Healthcare System, West Los Angeles, CA, USA
J Clin Oncol 31:2716-23. 2013..With data from a national Veterans Health Administration (VHA) study on quality of care, we sought to determine what proportion of patients refused or had a contraindication to recommended lung cancer therapy...
- Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance ConsortiumJohn Z Ayanian
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
J Clin Oncol 22:2992-6. 2004
- Quality of supportive care for patients with advanced cancer in a VA medical centerJennifer L Malin
VA Greater Los Angeles Healthcare System, RAND Health, David Geffen School of Medicine, University of California, Los Angeles, USA
J Palliat Med 14:573-7. 2011....
- Quality of breast cancer care: what do we know?Jennifer L Malin
Department of Medicine, Jonsson Comprehensive Cancer Center, University of California Los Angeles, 90095 1736, USA
J Clin Oncol 20:4381-93. 2002..To critically review studies that describe patterns of care for breast cancer patients and to examine the data sources used for case identification and determining patterns of care...
- Physician and Practice Characteristics Influencing Tumor Board Attendance: Results From the Provider Survey of the Los Angeles Women's Health StudyKevin S Scher
Department of Medicine, University of California, Los Angeles UCLA, Los Angeles David Geffen School of Medicine at UCLA, Veterans Affairs Greater Los Angeles Healthcare System, Sepulveda RAND Corporation, Santa Monica UCLA School of Public Health, Jonsson Comprehensive Cancer Center, Los Angeles, CA
J Oncol Pract 7:103-10. 2011..Tumor boards may provide a mechanism for improving coordination of care. We evaluated physician and practice characteristics that predict frequency of tumor board attendance...
- The value of specialty oncology drugsDana P Goldman
Schaeffer Center for Health Policy and Economics, Schools of Pharmacy and Policy, Planning, and Development, University of Southern California, Ralph and Goldy Lewis Hall 214, Los Angeles, CA 90089 0626, USA
Health Serv Res 45:115-32. 2010..To estimate patients' elasticity of demand, willingness to pay, and consumer surplus for five high-cost specialty medications treating metastatic disease or hematologic malignancies...
- Preoperative breast MRI in early-stage breast cancerPatricia Young
Cedars Sinai Medical Center, 8700 Beverly Blvd Suite 5512, Los Angeles, CA 90048, USA
Breast Cancer Res Treat 135:907-12. 2012..6-33 % reported in the literature). Routine preoperative breast MRI appears to confer no advantage over the standard diagnostic evaluations for early-stage breast cancer and may lead to worse patient outcomes...
- Documentation and discussion of preferences for care among patients with advanced cancerSangeeta C Ahluwalia
Center for the Study of Healthcare Provider Behavior, Veterans Administration Greater Los Angeles Healthcare System Veterans Administration Greater Los Angeles Healthcare System Cedars Sinai Medical Center University of California, Los Angeles UCLA School of Public Health Geffen School of Medicine at UCLA, Los Angeles, CA
J Oncol Pract 7:361-6. 2011..We sought to describe the documentation, frequency, and timing of discussions about patient preferences for care and to examine patterns of palliative care and hospice use among patients with advanced cancer...
- Using cost-effectiveness analysis to define a breast cancer benefits package for the uninsuredJennifer L Malin
Department of Medicine, University of California, Los Angeles 90095 1736, USA
Breast Cancer Res Treat 74:143-53. 2002..In 1999, California was considering legislation to fund breast cancer treatment for its uninsured. We sought to define the most cost-effective breast cancer benefits package in order to inform this debate...
- End-of-life care discussions among patients with advanced cancer: a cohort studyJennifer W Mack
Dana Farber Cancer Institute, Children s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Ann Intern Med 156:204-10. 2012..National guidelines recommend that physicians discuss end-of-life (EOL) care planning with patients with cancer whose life expectancy is less than 1 year...
- The cost-quality trade-off: need for data quality standards for studies that impact clinical practice and health policyJennifer L Malin
J Clin Oncol 23:4581-4. 2005
- Access to care is requisite but not sufficient for quality cancer careJennifer L Malin
Cancer Invest 23:568-70. 2005
- Bridging the divide: integrating cancer-directed therapy and palliative careJennifer L Malin
J Clin Oncol 22:3438-40. 2004
- Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care qualityEric C Schneider
Department of Health Policy Management, Harvard School of Public Health, Harvard University Brigham and Women s Hospital, Boston, MA, USA
J Clin Oncol 22:2985-91. 2004
- Do variations in provider discussions explain socioeconomic disparities in postmastectomy breast reconstruction?Caprice C Greenberg
Center for Surgery and Public Health, Division of Surgical Oncology, Brigham and Women s Hospital, Boston, MA 02115, USA
J Am Coll Surg 206:605-15. 2008..We investigated whether these differences reflect variations in the rate or qualitative aspects of the provider's discussion of reconstruction as an option...
- Surviving colorectal cancer : patient-reported symptoms 4 years after diagnosisEric C Schneider
Department of Health Policy and Management, Harvard School of Public Health, Section on Health Policy, Division of General Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Cancer 110:2075-82. 2007..The number of long-term survivors after a cancer diagnosis is increasing, yet relatively few studies have addressed survivors' reported symptoms beyond the initial year after diagnosis...